Electromagnetic interference of automatic implantable cardioverter defibrillator and heartware left ventricular assist device

ASAIO Journal

Volumn 59, Issue 2, 2013, Pages 136-139

  Labedi, Mohamed R ^a   Alharethi, Rami ^a   Kfoury, A G ^a   Budge, Deborah ^a   Bruce, Reid ^a   Rasmusson, Brad ^a   Bunch, T Jared ^a  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

electromagnetic interference; end stage heart failure; improper ICD shocks; left ventricular assist device

Indexed keywords

DEFIBRILLATION THRESHOLDS; DESTINATION THERAPY; DETECTION WINDOWS; DILATED CARDIOMYOPATHY; HEART FAILURE; IMPROPER ICD SHOCKS; LEFT VENTRICULAR ASSIST DEVICE (LVAD); REMOTE MONITORING;

CARDIOLOGY; CENTRIFUGAL PUMPS; ELECTROMAGNETIC PULSE; ELECTROMAGNETIC WAVE INTERFERENCE; IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; PATIENT TREATMENT; RELOCATION; SIGNAL INTERFERENCE;

LEFT VENTRICULAR ASSIST DEVICES;

HEPARIN;

AGED; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DEFIBRILLATION; ELECTROMAGNETIC FIELD; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC CARDIOMYOPATHY; MALE; HEART ASSIST DEVICE;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTROMAGNETIC PHENOMENA; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE;

EID: 84874873149     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318285fe93     Document Type: Article

References (21)

1. The Antiarrhythmics versus Implantable Defbrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defbrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576-1583, 1997.
2. Bardy GH, Lee KL, Mark DB, et al Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defbrillator for congestive heart failure. N Engl J Med 352: 225-237, 2005.
3. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafey G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341: 1882-1890, 1999.
4. Cleland JG, Daubert JC, Erdmann E, et al; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539-1549, 2005.
5. Kadish A, Dyer A, Daubert J P, et al; Defbrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators: Prophylactic defbrillator implantation in patients with nonisch-emic dilated cardiomyopathy. N Engl J Med 350: 2151-2158, 2004.
6. Moss AJ, Hall WJ, Cannom DS, et al: Improved survival with an implanted defbrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defbrillator Implantation Trial Investigators. N Engl J Med 335: 1933-1940, 1996.
7. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defbrillator Implantation Trial II Investigators: Prophylactic implantation of a defbrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877-883, 2002.
8. Bigger JT Jr, Whang W, Rottman JN, et al: Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defbrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 99: 1416-1421, 1999.
9. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ: Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analy-sis of randomized controlled trials. Eur Heart J 27: 2682-2688, 2006.
10. Roger VL, Weston SA, Redfeld MM, et al: Trends in heart failure incidence and survival in a community-based population. JAMA 292: 344-350, 2004.
11. Park SJ, Milano CA, Tatooles AJ, et al; HeartMate II Clinical Investigators: Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 5: 241-248, 2012.
12. Nativi JN, Drakos SG, Kucheryavaya AY, et al: Changing outcomes in patients bridged to heart transplantation with continuousversus pulsatile-flow ventricular assist devices: An analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 30: 854-861, 2011.
13. Boyle AJ, Ascheim DD, Russo MJ, et al: Clinical outcomes for continuous-fow left ventricular assist device patients strati-fed by pre-operative INTERMACS classifcation. J Heart Lung Transplant 30: 402-407, 2011.
14. Miller LW, Pagani FD, Russell SD, et al; HeartMate II Clinical Investigators: Use of a continuous-fow device in patients awaiting heart transplantation. N Engl J Med 357: 885-896, 2007.
15. Occhetta E, Bortnik M, Magnani A, Francalacci G, Marino P: Inappropriate implantable cardioverter-defbrillator discharges unrelated to supraventricular tachyarrhythmias. Europace 8: 863-869, 2006.
16. Matthews JC, Betley D, Morady F, Pelosi F Jr: Adverse interaction between a left ventricular assist device and an implant-able cardioverter defbrillator. J Cardiovasc Electrophysiol 18: 1107-1108, 2007.
17. Foo D, Walker BD, Kuchar DL, et al: Left ventricular mechanical assist devices and cardiac device interactions: an observational case series. Pacing Clin Electrophysiol 32: 879-887, 2009.
18. Kühne M, Sakumura M, Reich SS, et al: Simultaneous use of implantable cardioverter-defbrillators and left ventricular assist devices in patients with severe heart failure. Am J Cardiol 105: 378-382, 2010.
19. Reddy P, Benditt DG, Adabag S: Electromagnetic device-device interaction between a new generation implantable pacemaker and left ventricular assist device: Recognition and potential solutions. Pacing Clin Electrophysiol 35: e52-e54, 2012.
20. Seidman SJ, Brockman R, Lewis BM, et al: In vitro tests reveal sample radiofrequency identifcation readers inducing clinically signifcant electromagnetic interference to implantable pacemakers and implantable cardioverter-defbrillators. Heart Rhythm 7: 99-107, 2010.
21. Ambardekar AV, Allen LA, Lindenfeld J, et al: Implantable cardioverter-defbrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant 29: 771-776, 2010.